{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:34:31Z","timestamp":1792787671028,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phrs.2024.107489","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T07:49:52Z","timestamp":1730792992000},"page":"107489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy"],"prefix":"10.1016","volume":"210","author":[{"given":"Xu","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongdan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langfan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10-11","key":"10.1016\/j.phrs.2024.107489_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.addr.2011.05.021","article-title":"Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations","volume":"63","author":"Hamdy","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2024.107489_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ctrv.2011.11.008","article-title":"Adjuvant immunotherapy for non-small cell lung cancer","volume":"38","author":"Tucker","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"7528","key":"10.1016\/j.phrs.2024.107489_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2024.107489_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2024.107489_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"7693","key":"10.1016\/j.phrs.2024.107489_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2024.107489_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.it.2019.04.002","article-title":"Adverse events following cancer immunotherapy: obstacles and opportunities","volume":"40","author":"Pauken","year":"2019","journal-title":"Trends Immunol."},{"issue":"6382","key":"10.1016\/j.phrs.2024.107489_bib9","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Sci. (N. Y., NY)"},{"key":"10.1016\/j.phrs.2024.107489_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107489_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12499","article-title":"Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107489_bib12","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41467-018-04703-w","article-title":"Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy","volume":"9","author":"Ni","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2024.107489_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201906711","article-title":"Supramolecular nanodiscs self-assembled from non-ionic heptamethine cyanine for imaging-guided cancer photothermal therapy","volume":"32","author":"Mu","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107489_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201670109","article-title":"Mitochondria-targeted small-molecule fluorophores for dual modal cancer phototherapy","author":"Luo","year":"2016","journal-title":"Adv. Funct. Mater. 17\/2016"},{"issue":"38","key":"10.1016\/j.phrs.2024.107489_bib15","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1021\/jacs.6b06663","article-title":"Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy","volume":"138","author":"Lu","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.phrs.2024.107489_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107300","article-title":"Photosensitizer nanodot eliciting immunogenicity for photo-immunologic therapy of postoperative methicillin-resistant infection and secondary recurrence","volume":"34","author":"Tang","year":"2022","journal-title":"Adv. Mater."},{"issue":"50","key":"10.1016\/j.phrs.2024.107489_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202004905","article-title":"Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy","volume":"16","author":"Hu","year":"2020","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.phrs.2024.107489_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2024.107489_bib19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.phrs.2024.107489_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111958","article-title":"Pro-tumoral inflammatory myeloid cells as emerging therapeutic targets","volume":"17","author":"Szebeni","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2024.107489_bib21","doi-asserted-by":"crossref","first-page":"E415","DOI":"10.1073\/pnas.1211850110","article-title":"Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery","volume":"110","author":"Predina","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6230","key":"10.1016\/j.phrs.2024.107489_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.phrs.2024.107489_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"25","key":"10.1016\/j.phrs.2024.107489_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003951","article-title":"Application potential of toll-like receptors in cancer immunotherapy: systematic review","volume":"95","author":"Shi","year":"2016","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.phrs.2024.107489_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni0602-499","article-title":"Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848","volume":"3","author":"Jurk","year":"2002","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107489_bib27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.15252\/emmm.201403918","article-title":"TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence","volume":"6","author":"Ye","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"8","key":"10.1016\/j.phrs.2024.107489_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.phrs.2024.107489_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2007.02.025","article-title":"Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies","volume":"47","author":"Pockros","year":"2007","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107489_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ecp.11.5","article-title":"The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system","volume":"4","author":"Engel","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107489_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"429","key":"10.1016\/j.phrs.2024.107489_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3682","article-title":"In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2024.107489_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","article-title":"Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure","volume":"16 5","author":"Evans","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6383","key":"10.1016\/j.phrs.2024.107489_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acs.molpharmaceut.7b00976","article-title":"Binding of tolperisone hydrochloride with human serum albumin: effects on the conformation, thermodynamics, and activity of HSA","volume":"15","author":"Rabbani","year":"2018","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.phrs.2024.107489_bib36","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1021\/acs.bioconjchem.8b00708","article-title":"On the mechanisms of uptake of tumor-seeking cyanine dyes","volume":"29","author":"Usama","year":"2018","journal-title":"Bioconj. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2024.107489_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/acs.bioconjchem.9b00771","article-title":"Role of albumin in accumulation and persistence of tumor-seeking cyanine dyes","volume":"31","author":"Usama","year":"2020","journal-title":"Bioconj. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2024.107489_bib38","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1021\/acs.accounts.0c00733","article-title":"Hows and whys of tumor-seeking dyes","volume":"54","author":"Usama","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"43","key":"10.1016\/j.phrs.2024.107489_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704196","article-title":"Structure-guided design and synthesis of a mitochondria-targeting near-infrared fluorophore with multimodal therapeutic activities","volume":"29","author":"Tan","year":"2017","journal-title":"Adv. Mater."},{"issue":"34","key":"10.1016\/j.phrs.2024.107489_bib40","article-title":"Rationally designed heptamethine cyanine photosensitizers that amplify tumor-specific endoplasmic reticulum stress and boost antitumor immunity","volume":"18","author":"Huang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.phrs.2024.107489_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120306","article-title":"Near-infrared fluorescent coatings of medical devices for image-guided surgery","volume":"261","author":"Ashoka","year":"2020","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.phrs.2024.107489_bib42","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acs.molpharmaceut.6b01124","article-title":"Biophysical study on the interaction between eperisone hydrochloride and human serum albumin using spectroscopic, calorimetric, and molecular docking analyses","volume":"14","author":"Rabbani","year":"2017","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2024.107489_bib43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1006\/jmbi.2000.5208","article-title":"Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids","volume":"314","author":"Petitpas","year":"2001","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107489_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nri3843","article-title":"Fever and the thermal regulation of immunity: the immune system feels the heat","volume":"15","author":"Evans","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107489_bib45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acs.accounts.9b00148","article-title":"Combining nanomedicine and immunotherapy","volume":"52","author":"Shi","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.phrs.2024.107489_bib46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-065X.2007.00572.x","article-title":"Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity","volume":"220","author":"Krieg","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2024.107489_bib47","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fimmu.2018.00608","article-title":"Factors influencing the differentiation of human monocytic myeloid-derived suppressor cells into inflammatory macrophages","volume":"9","author":"Bayik","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107489_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14919","article-title":"IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population","volume":"8","author":"Nascimento","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.phrs.2024.107489_bib50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2024.107489_bib51","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/adma.201404308","article-title":"An imagable and photothermal \"Abraxane-like\" nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors","volume":"27","author":"Chen","year":"2015","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.phrs.2024.107489_bib52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0092-8674(05)80055-8","article-title":"Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7\/BB1 in interleukin-2 production and immunotherapy","volume":"71","author":"Schwartz","year":"1992","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2024.107489_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"van Elsas","year":"1999","journal-title":"J. Exp. Med."},{"issue":"6475","key":"10.1016\/j.phrs.2024.107489_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice","volume":"369","author":"K\u00e4gi","year":"1994","journal-title":"Nature"},{"issue":"52","key":"10.1016\/j.phrs.2024.107489_bib55","article-title":"Massively evoking immunogenic cell death by focused mitochondrial oxidative stress using an aie luminogen with a twisted molecular structure","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"issue":"31","key":"10.1016\/j.phrs.2024.107489_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101155","article-title":"Acidity-activatable dynamic nanoparticles boosting ferroptotic cell death for immunotherapy of cancer","volume":"33","author":"Song","year":"2021","journal-title":"Adv. Mater."},{"issue":"7446","key":"10.1016\/j.phrs.2024.107489_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"7203","key":"10.1016\/j.phrs.2024.107489_bib60","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2024.107489_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2024.107489_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.phrs.2024.107489_bib63","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1172\/JCI67655","article-title":"MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis","volume":"123","author":"Cook","year":"2013","journal-title":"J. Clin. Investig."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:47:36Z","timestamp":1734522456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824004341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":63,"alternative-id":["S1043661824004341"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107489","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107489"}}